management & research for ctcl at the city of hope
Published 6 years ago • 75 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
1:52
critical insight into therapeutic progress for ctcl
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
0:57
novel targets in the treatment of ctcl
-
1:56
the current landscape of all therapy research
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
1:32
unanswered questions in mcl: when will we achieve cure?
-
12:45
strides made in biomedical engineering in zambia by biomedical engineering association of zambia
-
9:25
mgus diagnosis: a step-by-step approach
-
52:32
what is a clinical trial management system (ctms)?
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
1:39
session highlights: the value of clinical hematology research groups
-
3:35
an e-learning tool for hematology-oncology nurses
-
1:18
involving the patient in treatment decisions for cll
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
3:56
real world data for cll management
-
5:15
the promise of immunotherapies in t-cell lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:48
the promise of pyruvate kinase activators, such as mitapivat, for treating scd and thalassemia